Only one-third of manufacturing is currently conducted in-house, from development stages to after commercial launch, according a recent report.
The report, published by Industry Standard Research (ISR), explained that the majority of work is outsourced – and mainly to preferred providers, who are netting the largest portion of work.
According to Kate Hammeke, Vice President of Market Research at Industry Standard Research, this puts a high level of demand on contract manufacturing organization services, in particular areas such as specialty dosage forms.
“Some of the many surprising findings came from ISR’s investigation into how internal resources like available capacity and staff scientific expertise influence the decision or requirement to outsource.” Hammeke told us.
Continue reading: https://www.outsourcing-pharma.com/Contract-Manufacturing/Two-thirds-of-pharmaceutical-manufacturing-is-outsourced-ISR-Reports
